Citigroup »

Ambrx Biopharma shares owned by Citigroup

Quarter-by-quarter ownership of Ambrx Biopharma shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Ambrx Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Ambrx Biopharma held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ambrx Biopharma by Citigroup

Quarter filed Position value Share count Share price at filing
2023-12-31 $267k 19k 14.24

More positions owned by Citigroup

Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Ishares Tr Msci Emg Mkt Etf (EEM)
Tesla Motors (TSLA)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)

View all positions for Citigroup

Top funds holding Ambrx Biopharma

Federated Investors
Alliancebernstein
Altitude Crest Partners
Virtu Financial

View all funds holding Ambrx Biopharma